© 1986 Oxford University Press
other |
Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues
Hematology-Oncology Division, Department of Medicine and the R.L. Ireland Cancer Center, University Hospitals of Cleveland, Case Western Reserve University Medical School 2074 Abington Road, Cleveland, OH 44106, USA
1To whom reprint requests should be sent
O6-Alkylguanine-DNA alkyltransferase (alkyltransferase) is the repair protein for O6-alkylguanine, a pre-mutagenic adduct formed by a variety of alkylating agents. Previous comparisons of the repair capacity of O6-alkylguanine in different tissues have expressed the alkyltransferase activity relative to total protein, and have asserted that tissues with low levels of activity were at greater risk for mutagenic damage than tissues with higher levels of activity. Because the alkyltransferase uses DNA as substrate, and because tissues vary greatly in protein content, comparisons of tissue alkyltransferase activity may be more appropriately based on cellular DNA content. We compared alkyltransferase activity relative to tissue DNA content with the activity related to protein content in human, rat and mouse tissues. In each species, liver containing the highest level of activity using either method. In agreement with the findings of others, low levels of alkyltransferase activity relative to protein were seen in human brain, rat brain and small intestine, and mouse kidney. However, based on alkyltransferase activity relative to DNA content, low levels of activity were seen in human bone marrow myeloid precursors, rat bone marrow, brain and intestine, and mouse spleen and bone marrow. The range of activity between tissues was 18-fold in human, 15-fold in rat and 8-fold in mouse. In general, the rank of alkyltransferase activity relative to DNA for each tissue was human > rat > mouse. These results suggest that the mouse is more susceptible to nitrosoureas than rat or human. In each species, the organs with low levels of alkyltransferase activity relative to tissue DNA content would appear to be targets for mutagenic damage following nitrosourea exposure.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. B. Kirkland Niacin status and treatment-related leukemogenesis Mol. Cancer Ther., April 1, 2009; 8(4): 725 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Hegi, L. Liu, J. G. Herman, R. Stupp, W. Wick, M. Weller, M. P. Mehta, and M. R. Gilbert Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity J. Clin. Oncol., September 1, 2008; 26(25): 4189 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Sandercock, J. N. Hahn, L. Li, H.A. Luchman, J. L. Giesbrecht, L. A. Peterson, and F. R. Jirik Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Carcinogenesis, April 1, 2008; 29(4): 866 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N P Lees, K L Harrison, C N Hall, G P Margison, and A C Povey Human colorectal mucosal O6-alkylguanine DNA-alkyltransferase activity and DNA-N7-methylguanine levels in colorectal adenoma cases and matched referents Gut, March 1, 2007; 56(3): 380 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Niture, C. S. Velu, Q. R. Smith, G.J. Bhat, and K. S. Srivenugopal Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines Carcinogenesis, February 1, 2007; 28(2): 378 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ishiguro, H. A. Seow, P. G. Penketh, K. Shyam, and A. C. Sartorelli Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazine. Mol. Cancer Ther., April 1, 2006; 5(4): 969 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liu and S. L. Gerson Targeted Modulation of MGMT: Clinical Implications Clin. Cancer Res., January 15, 2006; 12(2): 328 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ishiguro, K. Shyam, P. G. Penketh, and A. C. Sartorelli Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine Mol. Cancer Ther., November 1, 2005; 4(11): 1755 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Margison, J. Heighway, S. Pearson, G. McGown, M. R. Thorncroft, A. J. Watson, K. L. Harrison, S. J. Lewis, K. Rohde, P. V. Barber, et al. Quantitative trait locus analysis reveals two intragenic sites that influence O6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cells Carcinogenesis, August 1, 2005; 26(8): 1473 - 1480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Konishi, M. Nakamura, E. Ishida, K. Shimada, E. Mitsui, R. Yoshikawa, H. Yamamoto, and K. Tsujikawa High Expression of a New Marker PCA-1 in Human Prostate Carcinoma Clin. Cancer Res., July 15, 2005; 11(14): 5090 - 5097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Hong, N. D. Turner, R. J. Carroll, R. S. Chapkin, and J. R. Lupton Differential Response to DNA Damage May Explain Different Cancer Susceptibility Between Small and Large Intestine Experimental Biology and Medicine, July 1, 2005; 230(7): 464 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Osanai, Y. Takagi, Y. Toriya, T. Nakagawa, T. Aruga, S. Iida, H. Uetake, and K. Sugihara Inverse Correlation Between the Expression of O6-Methylguanine-DNA Methyl Transferase (MGMT) and p53 in Breast Cancer Jpn. J. Clin. Oncol., March 1, 2005; 35(3): 121 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Lees, K. L. Harrison, C. N. Hall, G. P. Margison, and A. C. Povey Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC->AT transition mutations in a population exposed to methylating agents Carcinogenesis, July 1, 2004; 25(7): 1243 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Margison, A. C. Povey, B. Kaina, and M. F. Santibanez Koref Variability and regulation of O6-alkylguanine-DNA alkyltransferase Carcinogenesis, April 1, 2003; 24(4): 625 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. P. Charge, A. S. Brack, and S. M. Hughes Aging-related satellite cell differentiation defect occurs prematurely after Ski-induced muscle hypertrophy Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1228 - C1241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Buschfort-Papewalis, T. Moritz, B. Liedert, and J. Thomale Down-regulation of DNA repair in human CD34+ progenitor cells corresponds to increased drug sensitivity and apoptotic response Blood, July 18, 2002; 100(3): 845 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liu, S. Schwartz, B. M. Davis, and S. L. Gerson Chemotherapy-induced O6-Benzylguanine-resistant Alkyltransferase Mutations in Mismatch-deficient Colon Cancer Cancer Res., June 1, 2002; 62(11): 3070 - 3076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Gerson Clinical Relevance of MGMT in the Treatment of Cancer J. Clin. Oncol., May 1, 2002; 20(9): 2388 - 2399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Roth and L. D. Samson 3-Methyladenine DNA Glycosylase-deficient Aag Null Mice Display Unexpected Bone Marrow Alkylation Resistance Cancer Res., February 1, 2002; 62(3): 656 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Boyonoski, J. C. Spronck, L. M. Gallacher, R. M. Jacobs, G. M. Shah, G. G. Poirier, and J. B. Kirkland Niacin Deficiency Decreases Bone Marrow Poly(ADP-Ribose) and the Latency of Ethylnitrosourea-Induced Carcinogenesis in Rats J. Nutr., January 1, 2002; 132(1): 108 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Boyonoski, J. C. Spronck, R. M. Jacobs, G. M. Shah, G. G. Poirier, and J. B. Kirkland Pharmacological Intakes of Niacin Increase Bone Marrow Poly(ADP-Ribose) and the Latency of Ethylnitrosourea-Induced Carcinogenesis in Rats J. Nutr., January 1, 2002; 132(1): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Peterson, N. M. Thomson, D. L. Crankshaw, E. E. Donaldson, and P. J. Kenney Interactions between Methylating and Pyridyloxobutylating Agents in A/J Mouse Lungs: Implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced Lung Tumorigenesis Cancer Res., August 1, 2001; 61(15): 5757 - 5763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, T. P. Spiro, X. Qin, S. Majka, J. Haaga, J. Schupp, J. K. V. Willson, and S. L. Gerson Differential Degradation Rates of Inactivated Alkyltransferase in Blood Mononuclear Cells and Tumors of Patients after Treatment with O6-Benzylguanine Clin. Cancer Res., August 1, 2001; 7(8): 2318 - 2324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Kreklau, N. Liu, Z. Li, K. Cornetta, and L. C. Erickson Comparison of Single- Versus Double-Bolus Treatments of O6-Benzylguanine for Depletion of O6-Methylguanine DNA Methyltransferase (MGMT) Activity in Vivo: Development of a Novel Fluorometric Oligonucleotide Assay for Measurement of Mgmt Activity J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 524 - 530. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. H. Bielas and J. A. Heddle Proliferation is necessary for both repair and mutation in transgenic mouse cells PNAS, September 22, 2000; (2000) 190330997. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Suh, U. G. Kang, Y. S. Kim, W.-H. Kim, S.-C. Park, and J.-B. Park Differential Activation of c-Jun NH2-terminal Kinase and p38 Mitogen-activated Protein Kinases by Methyl Methanesulfonate in the Liver and Brain of Rats: Implication for Organ-specific Carcinogenesis Cancer Res., September 1, 2000; 60(18): 5067 - 5073. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. J. O'Connor, F. C.R. Manning, A. T. Gordon, M. A. Billett, D. P. Cooper, R. H. Elder, and G. P. Margison Thresholds for Genotoxic Carcinogens: DNA Repair: Kinetics and Thresholds Toxicol Pathol, May 1, 2000; 28(3): 375 - 381. [Abstract] [PDF]
|
|
|
|
|
|
A. C. Boyonoski, L. M. Gallacher, M. M. ApSimon, R. M. Jacobs, G. M. Shah, G. G. Poirier, and J. B. Kirkland Niacin Deficiency in Rats Increases the Severity of Ethylnitrosourea-Induced Anemia and Leukopenia J. Nutr., May 1, 2000; 130(5): 1102 - 1107. [Abstract] [Full Text]
|
|
|
|
|
|
H. Kawate, R. Itoh, K. Sakumi, Y. Nakabeppu, T. Tsuzuki, F. Ide, T. Ishikawa, T. Noda, H. Nawata, and M. Sekiguchi A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice Carcinogenesis, February 1, 2000; 21(2): 301 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Srivenugopal, S. R. S. Mullapudi, J. Shou, T. K. Hazra, and F. Ali-Osman Protein Phosphorylation Is a Regulatory Mechanism for O6-Alkylguanine-DNA Alkyltransferase in Human Brain Tumor Cells Cancer Res., January 1, 2000; 60(2): 282 - 287. [Abstract] [Full Text]
|
|
|
|
|
|
E. Alvino, R. Pepponi, E. Pagani, P. M. Lacal, C. Nunziata, E. Bonmassar, and S. D'Atri O6-Benzylguanine Enhances the In Vitro Immunotoxic Activity of Temozolomide on Natural or Antigen-Dependent Immunity J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1292 - 1300. [Abstract] [Full Text]
|
|
|
|
|
|
R. K. Wali, S. Skarosi, J. Hart, Y. Zhang, M.e. Dolan, R. C. Moschel, L. Nguyen, R. Mustafi, T. A. Brasitus, and M. Bissonnette Inhibition of O6-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats Carcinogenesis, December 1, 1999; 20(12): 2355 - 2360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Hickman and L. D. Samson Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents PNAS, September 14, 1999; 96(19): 10764 - 10769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Maze, C. Kurpad, A. E. Pegg, L. C. Erickson, and D. A. Williams Retroviral-Mediated Expression of the P140A, but not P140A/G156A, Mutant Form of O6-Methylguanine DNA Methyltransferase Protects Hematopoietic Cells against O6-Benzylguanine Sensitization to Chloroethylnitrosourea Treatment J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1467 - 1474. [Abstract] [Full Text]
|
|
|
|
|
|
X. Qin, H. Zhou, L. Liu, and S. L. Gerson Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis Carcinogenesis, September 1, 1999; 20(9): 1667 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. S. O’Donnell, P. V. Barber, G. P. Margison, and A. C. Povey Association between O6-Alkylguanine-DNA-alkyltransferase Activity in Peripheral Blood Lymphocytes and Bronchial Epithelial Cells Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 641 - 645. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. J. Glassner, G. Weeda, J. M. Allan, J. L.M. Broekhof, N. H.E. Carls, I. Donker, B. P. Engelward, R. J. Hampson, R. Hersmus, M. J. Hickman, et al. DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents Mutagenesis, May 1, 1999; 14(3): 339 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. P. Spiro, S. L. Gerson, L. Liu, S. Majka, J. Haaga, C. L. Hoppel, S. T. Ingalls, J. M. Pluda, and J. K. V. Willson O6-Benzylguanine: A Clinical Trial Establishing the Biochemical Modulatory Dose in Tumor Tissue for Alkyltransferase-directed DNA Repair Cancer Res., May 1, 1999; 59(10): 2402 - 2410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Silber, A. Blank, M. S. Bobola, S. Ghatan, D. D. Kolstoe, and M. S. Berger O6-Methylguanine-DNA Methyltransferase-deficient Phenotype in Human Gliomas: Frequency and Time to Tumor Progression after Alkylating Agent-based Chemotherapy Clin. Cancer Res., April 1, 1999; 5(4): 807 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Gerson, J. Schupp, L. Liu, A. E. Pegg, and S. Srinivasen Leukocyte O6-Alkylguanine-DNA Alkyltransferase from Human Donors Is Uniformly Sensitive to O6-Benzylguanine Clin. Cancer Res., March 1, 1999; 5(3): 521 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Esteller, S. R. Hamilton, P. C. Burger, S. B. Baylin, and J. G. Herman Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation is a Common Event in Primary Human Neoplasia Cancer Res., February 1, 1999; 59(4): 793 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Liu, X. Qin, and S. L. Gerson Reduced lung tumorigenesis in human methylguanine DNA—methyltransferase transgenic mice achieved by expression of transgene within the target cell Carcinogenesis, February 1, 1999; 20(2): 279 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Mostafa, S. A. Sheweita, and P. J. O'Connor Relationship between Schistosomiasis and Bladder Cancer Clin. Microbiol. Rev., January 1, 1999; 12(1): 97 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Reese, B. M. Davis, L. Liu, and S. L. Gerson Simultaneous Protection of G156A Methylguanine DNA Methyltransferase Gene-transduced Hematopoietic Progenitors and Sensitization of Tumor Cells Using O6-Benzylguanine and Temozolomide Clin. Cancer Res., January 1, 1999; 5(1): 163 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Engelbergs, J. Thomale, A. Galhoff, and M. F. Rajewsky Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea PNAS, February 17, 1998; 95(4): 1635 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. K. Hansen, W. A. Deutsch, A. Yacoub, Y. Xu, D. A. Williams, and M. R. Kelley Creation of a Fully Functional Human Chimeric DNA Repair Protein. COMBINING O6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) AND AP ENDONUCLEASE (APE/REDOX EFFECTOR FACTOR 1 (Ref 1)) DNA REPAIR PROTEINS J. Biol. Chem., January 9, 1998; 273(2): 756 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Y. Chen, L. C. Harris, J. S. Remack, and T. P. Brent Cytoplasmic sequestration of an O6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells PNAS, April 29, 1997; 94(9): 4348 - 4353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Chinnasamy, J. A. Rafferty, I. Hickson, J. Ashby, H. Tinwell, G. P. Margison, T. M. Dexter, and L. J. Fairbairn O6-Benzylguanine Potentiates the In Vivo Toxicity and Clastogenicity of Temozolomide and BCNU in Mouse Bone Marrow Blood, March 1, 1997; 89(5): 1566 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Reese, O. N. Koc, K. M. Lee, L. Liu, J. A. Allay, W. P. Phillips Jr., and S. L. Gerson Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosourea PNAS, November 26, 1996; 93(24): 14088 - 14093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Dumenco, E Allay, K Norton, and S. Gerson The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase Science, January 8, 1993; 259(5092): 219 - 222. [Abstract] [PDF]
|
|
|
|
 |
|
 C. C. Hull, P. Galloway, N. Gordon, S. L. Gerson, N. Hawkins, and T. A. Stellato Splenectomy and the Induction of Murine Colon Cancer Arch Surg, April 1, 1988; 123(4): 462 - 464. [Abstract] [PDF]
|
|
|
|
|
|
J. H. Bielas and J. A. Heddle From the Cover: Proliferation is necessary for both repair and mutation in transgenic mouse cells PNAS, October 10, 2000; 97(21): 11391 - 11396. [Abstract] [Full Text] [PDF]
|
|